Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori.

作者: Gail B. Mahady , Susan L. Pendland , Gina S. Yun , Adina Stoia , Zhi Zhen Lu

DOI:

关键词: Helicobacter pyloriBacteriaCagAIn vitroSpirillaceaeTraditional medicineZingiber officinaleMedicineMinimum inhibitory concentrationPolyphenol

摘要: Background Ginger root (Zingiber officinale) has been used traditionally for the treatment of gastrointestinal ailments such as motion sickness, dyspepsia and hyperemesis gravidarum, is also reported to have chemopreventative activity in animal models. The gingerols are a group structurally related polyphenolic compounds isolated from ginger known be active constituents. Since Helicobacter pylori (HP) primary etiological agent associated with dyspepsia, peptic ulcer disease development gastric colon cancer, anti-HP effects its constituents were tested vitro. Materials methods A methanol extract dried powdered rhizome, fractions constituents, 6-,8-,10-gingerol 6-shogoal, against 19 strains HP, including 5 CagA+ strains. Results rhizome inhibited growth all vitro minimum inhibitory concentration range 6.25-50 micrograms/ml. One fraction crude extract, containing gingerols, was HP an MIC 0.78 12.5 micrograms/ml significant Conclusion These data demonstrate that extracts inhibit H. this may contribute effects.

参考文章(17)
Eun Jung Park, John M. Pezzuto, Botanicals in Cancer Chemoprevention Cancer and Metastasis Reviews. ,vol. 21, pp. 231- 255 ,(2002) , 10.1023/A:1021254725842
Santosh K. Katiyar, Hasan Mukhtar, Rajesh Agarwal, Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Research. ,vol. 56, pp. 1023- 1030 ,(1996)
S. Censini, C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, A. Covacci, cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 14648- 14653 ,(1996) , 10.1073/PNAS.93.25.14648
Naoki Yoshimi, Aijin Wang, Yukio Morishita, Takuji Tanaka, Shigeyuki Sugie, Kiyoshi Kawai, Joji Yamahara, Hideki Mori, Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Japanese Journal of Cancer Research. ,vol. 83, pp. 1273- 1278 ,(1992) , 10.1111/J.1349-7006.1992.TB02758.X
B. Breuer-Katschinski, K. Nemes, A. Marr, B. Rump, B. Leiendecker, N. Breuer, H. Goebell, Helicobacter pylori and the Risk of Colonic Adenomas Digestion. ,vol. 60, pp. 210- 215 ,(1999) , 10.1159/000007661
Haim Shmuely, Doug Passaro, Aryeh Figer, Yaron Niv, Silvio Pitlik, Zmira Samra, Rivka Koren, Jacob Yahav, Relationship between Helicobacter pylori CagA status and colorectal cancer. The American Journal of Gastroenterology. ,vol. 96, pp. 3406- 3410 ,(2001) , 10.1111/J.1572-0241.2001.05342.X
P. Correa, Bacterial infections as a cause of cancer. Journal of the National Cancer Institute. ,vol. 95, ,(2003) , 10.1093/JNCI/95.7.E3
A J Zuckerman, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Journal of Clinical Pathology. ,vol. 48, pp. 691- 691 ,(1995) , 10.1136/JCP.48.7.691-A